Get more replies from employers
Send a job-specific resume in minutes.
Fluxus Inc., located in Sunnyvale, CA, is looking for a highly motivated interdisciplinary Product Development Engineer. The ideal candidate will contribute to the design, testing, and development of innovative diagnostics platforms, specifically biochips and related instruments.
With a B.S. in mechanical or bioengineering and experience in R&D, you'll be essential in collaborating with different teams and external vendors while ensuring compliance with regulatory standards. Join us in advancing single-molecule detection and improve health diagnostics.
Sunnyvale, CA
To support its product development activities, Fluxus Inc. is seeking a highly motivated, interdisciplinary product development engineer with relevant, hands‑on experience. She/He will be part of the product development team and will play a vital role in product prototyping, design, testing and the implementation of manufacturing.
She/He will work closely with the other Fluxus teams and will integrate assays/reagents, consumables, instruments, and software. Activities will involve amongst others the development, optimization and manufacturing of functional biochips, fluidic cartridges and analytical instruments. The successful applicant will work within a multidisciplinary team of engineers, scientists and manufacturing personnel. Part of the activities might be conducted in a BSL2 laboratory area and could involve the handling of human patient fluid samples. Other activities might be conducted in a cleanroom setting.
Fluxus, Inc. is an innovator in single‑molecule detection and ultra‑high sensitivity platforms based on its expertise in optofluidics, assay development, system integration and microsystem technologies. The Fluxus product development infrastructure and suite of proprietary technologies are ideally suited for the robust development of advanced diagnostic products.
Fluxus is a leader in optofluidics that provides systems and solutions to advance the detection, diagnosis, monitoring, and treatment of disease. Our expertise lies at the interface of advanced photonics, MEMS, engineering, assay development, and reagent manufacturing excellence.
We seek to close a major gap in clinical research and diagnostics by bringing our groundbreaking ultrasensitive detection technologies and assay solutions to researchers, clinicians, patients, and key industry players through strong partnerships and a future‑proof portfolio of innovative products.
Fluxus was founded in 2016 and acquired in 2022 by Fujirebio Holdings, Inc., an R&D‑driven company developing novel IVD technologies and biomarkers with high clinical value.
Today, as a wholly owned subsidiary of Fujirebio, Fluxus represents a unique blend of Silicon Valley startup ingenuity with the stability and reach of an established multinational corporation. Our experienced, multidisciplinary team draws on deep and varied expertise to continuously innovate and drive towards our goal of becoming the gold standard in single molecule counting and ultrasensitive biomolecular testing.